Financial and legislative aspects of drug development of orphan diseases on the European market – a systematic review

about

Financial and legislative aspects of drug development of orphan diseases on the European market – a systematic review

Item

http://www.wikidata.org/entity/Q58261059

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2016

@uk

name

Financial and legislative aspe ...... n market – a systematic review

@en

Financial and legislative aspe ...... n market – a systematic review

@nl

type

Item

label

Financial and legislative aspe ...... n market – a systematic review

@en

Financial and legislative aspe ...... n market – a systematic review

@nl

prefLabel

Financial and legislative aspe ...... n market – a systematic review

@en

Financial and legislative aspe ...... n market – a systematic review

@nl

P1476

Financial and legislative aspe ...... n market – a systematic review

@en

P2093

Blanka Klimova

http://www.w3.org/2001/XMLSchema#string

Kamil Kuca

http://www.w3.org/2001/XMLSchema#string

Petra Maresova

http://www.w3.org/2001/XMLSchema#string

P2860

The current status of orphan drug development in Europe and the US

Ethical and legal framework and regulation for off-label use: European perspective

Review of mifamurtide in the treatment of patients with osteosarcoma.

The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?

Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty rats

Nonsteroidal antiinflammatory drugs (NSAIDs) and physiotherapy management of musculoskeletal conditions: a professional minefield?

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Estimating the budget impact of orphan drugs in Sweden and France 2013-2020.

Socio-economic Aspects of Alzheimer's Disease.

Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.

P304

2562-2570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00036846.2015.1125433

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

Orphan diseases